Dexcom Inc SEC filings DXCM

Dexcom Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 14, 2019. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, other events). The company's fiscal year ends on December 31.

Dexcom Inc SEC filings
Form Description Filed Period
SD Specialized disclosure (conflict minerals) May 28, 2026 —
SD Specialized disclosure (conflict minerals) May 29, 2025 —
SD Specialized disclosure (conflict minerals) May 29, 2024 —
SD Specialized disclosure (conflict minerals) May 31, 2023 —
SD Specialized disclosure (conflict minerals) May 31, 2022 —
UPLOAD Letter from the SEC May 5, 2022 —
CORRESP Letter to the SEC May 3, 2022 —
UPLOAD Letter from the SEC Apr 21, 2022 —
CORRESP Letter to the SEC Mar 29, 2022 —
UPLOAD Letter from the SEC Mar 22, 2022 —
SD Specialized disclosure (conflict minerals) Jun 1, 2021 —
SD Specialized disclosure (conflict minerals) Jun 1, 2020 —
SD Specialized disclosure (conflict minerals) May 30, 2019 —
CT ORDER Filing Mar 5, 2019 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
DXCM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1093557

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.